Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer.
Invest New Drugs. 2020 Dec;38(6):1872-1878. doi: 10.1007/s10637-020-00965-8. Epub 2020 Jun 26.
Invest New Drugs. 2020.
PMID: 32591974
Clinical Trial.
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.
Gorodnova TV, Kotiv KB, Ivantsov AO, Mikheyeva ON, Mikhailiuk GI, Lisyanskaya AS, Mikaya NA, Guseynov KD, Bondarev NE, Matveyeva NS, Nekrasova EA, Sidoruk AA, Roman LD, Manikhas GM, Belyaev AM, Sokolenko AP, Berlev IV, Imyanitov EN.
Gorodnova TV, et al. Among authors: kotiv kb.
Int J Gynecol Cancer. 2018 Oct;28(8):1498-1506. doi: 10.1097/IGC.0000000000001352.
Int J Gynecol Cancer. 2018.
PMID: 30247247
Item in Clipboard
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
Gorodnova TV, Sokolenko AP, Kotiv KB, Sokolova TN, Ivantsov AO, Guseynov KD, Nekrasova EA, Smirnova OA, Berlev IV, Imyanitov EN.
Gorodnova TV, et al. Among authors: kotiv kb.
Hered Cancer Clin Pract. 2021 Feb 3;19(1):14. doi: 10.1186/s13053-021-00173-2.
Hered Cancer Clin Pract. 2021.
PMID: 33536037
Free PMC article.
Item in Clipboard
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Sokolenko AP, Gorodnova TV, Bizin IV, Kuligina ES, Kotiv KB, Romanko AA, Ermachenkova TI, Ivantsov AO, Preobrazhenskaya EV, Sokolova TN, Broyde RV, Imyanitov EN.
Sokolenko AP, et al. Among authors: kotiv kb.
Cancer Chemother Pharmacol. 2021 Sep;88(3):439-450. doi: 10.1007/s00280-021-04301-6. Epub 2021 Jun 2.
Cancer Chemother Pharmacol. 2021.
PMID: 34080040
Item in Clipboard
Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.
Sokolenko AP, Savonevich EL, Ivantsov AO, Raskin GA, Kuligina ES, Gorodnova TV, Preobrazhenskaya EV, Kleshchov MA, Tiurin VI, Mukhina MS, Kotiv KB, Shulga AV, Kuznetsov SG, Berlev IV, Imyanitov EN.
Sokolenko AP, et al. Among authors: kotiv kb.
Cancer Lett. 2017 Jul 1;397:127-132. doi: 10.1016/j.canlet.2017.03.036. Epub 2017 Apr 1.
Cancer Lett. 2017.
PMID: 28377179
Item in Clipboard
Molecular profiles of BRCA1-associated ovarian cancer treated by platinum-based therapy: Analysis of primary, residual and relapsed tumors.
Sokolenko AP, Bizin IV, Preobrazhenskaya EV, Gorodnova TV, Ivantsov AO, Iyevleva AG, Savonevich EL, Kotiv KB, Kuligina ES, Imyanitov EN.
Sokolenko AP, et al. Among authors: kotiv kb.
Int J Cancer. 2020 Apr 1;146(7):1879-1888. doi: 10.1002/ijc.32776. Epub 2019 Nov 29.
Int J Cancer. 2020.
PMID: 31693165
Free article.
Item in Clipboard
Cite
Cite